No evidence for association of multiple sclerosis with the complement factors C6 and C7

Journal of Neuroimmunology

Volumn 99, Issue 1, 1999, Pages 150-156

  Chataway, Jeremy ^a   Sawcer, Stephen ^a   Sherman, David ^e   Hobart, Michael ^b   Fernie, Barbara ^b   Coraddu, Francesca ^a   Feakes, Robert ^a   Broadley, Simon ^a   Gray, Julia ^a   Jones, Hywel B ^c   Clayton, David ^c   Goodfellow, Peter N ^a   Compston, Alastair ^a,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Med Res Cncl HGMP Resource Centre   (United Kingdom)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d Forvie Site   (United Kingdom)

^e Univ Forvie Site Robinson Way C ^*

Author keywords

Chromosome 5; Complement; Multiple sclerosis; Oligoligation assay

Indexed keywords

COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7;

ARTICLE; CENTROMERE; CHROMOSOME 5; COMPLEMENT SYSTEM; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SIBLING;

AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; COMPLEMENT C6; COMPLEMENT C7; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; MALE; MULTIPLE SCLEROSIS; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 0032832164     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00054-5     Document Type: Article

References (47)

1. Barany F. Genetic disease detection and DNA amplification using a cloned thermostable ligase. Proc. Natl. Acad. Sci. USA. 88:1991;189-193.
2. Baron H., Fung S., Aydin A., Bahring S., Luft F.C., Schuster H. Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia. Nat. Biotechnol. 14:1996;1279-1282.
3. Bertrams, J., Opferkuch, W., Grosse-Wilde, H., Luboldt, W., Schuppien, W., Kuwert, E., 1976. C2 hypocomplementaemia in multiple sclerosis. Lancet, 1358-1359.
4. Bulman D.E., Armstrong H., Ebers G.C. Allele frequencies of the third component of complement (C3) in MS patients. J. Neurol., Neurosurg. Psychiatry. 54:1991;554-555.
5. Collins A., Frezal J., Teague J., Morton N.E. A metric map of humans: 23,500 loci in 850 bands. Proc. Natl. Acad. Sci. USA. 93:1996;14771-14775.
6. Compston D.A.S., Morgan B.P., Oleesky D., Fifield R., Campbell A.K. Cerebrospinal fluid C9 in demyelinating disease. Neurology. 36:1986;1503-1506.
7. Compston D.A.S., Morgan B.P., Campbell A.K. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15:1989;307-316.
8. Coraddu F., Sawcer S., Feakes R., Chataway J., Broadley S., Jones H.B., Clayton D., Gray J., Smith S., Taylor C., Goodfellow P.N., Compston D.A.S. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics. 2:1998;24-33.
9. Dyment D.A., Sadnovich A.D., Ebers G.C. Genetics of multiple sclerosis. Hum. Mol. Genet. 6:1997;1693-1698.
10. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R.B., Hader W., Paty D.W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J.E., Murray T.J., Pryse-Phillips W., Nelson R., Freedman M., Brunet D., Bouchard J.P., Hinds D., Risch N. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
11. Eggerding F.A., Iovannisci D.M., Brinson E., Grossman P., Winn-Deen E.S. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations. Hum. Mutat. 5:1995;153-165.
12. Fernie B.A., Orren A., Wurzner R., Jones A.M., Potter P.C., Lachmann P.J., Hobart M.J. Complement component C6 and C7 haplotypes associated with deficiencies of C6. Ann. Hum. Genet. 59:1995;183-195.
13. Fernie B.A., Wurzner R., Unsworth D.J., Tuxworth R.I., Hobart M.J. DNA polymorphisms of the complement C6 and C7 genes. Ann. Hum. Genet. 59:1995;163-181.
14. Fernie B.A., Orren A., Schlesinger M., Wurzner R., Platonov A.E., Cooper R.C., Williams Y.E., Hobart M.J. DNA haplotypes of the complement C6 and C7 genes associated with deficiencies of the seventh component; and a new DNA polymorphism in C7 exon 13. Ann. Hum. Genet. 61:1997;287-298.
15. Franciotta D., Dondi E., Bergamaschi R., Piccolo G., d'Eril G.V.M., Cosi V. HLA complement gene polymorphisms in multiple sclerosis: a study on 80 Italian patients. J. Neurol. 242:1995;64-68.
16. Francis D.A., Batchelor J.R., McDonald W.I., Hing S.N., Dodi I.A., Fielder A.H.et al. Multiple sclerosis in north-east Scotland: an association with HLA-DQw1. Brain. 110:1987;181-196.
17. Gay D., Esiri M. Blood-brain-barrier damage in acute multiple sclerosis plaques. Brain. 114:1991;557-572.
18. Gorodezky C., Najera R., Rangel B.E., Castro L.E., Flores J., Velazquez G. Immunogenetic profile of multiple sclerosis in Mexicans. Hum. Immunol. 16:1986;364-374.
19. Grossman P.D., Bloch W., Brinson E., Chang C.C., Eggerding F.A., Fung S., Iovannisci D.A., Woo S., Winn-Deen E.S. High-density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. Nucleic Acids Res. 22:1994;4527-4534.
20. Grossman P.D., Fung S., Menchen S.M., Woo S.L., Winn-Deen E.S. Method and probe composition for detecting multiple sequences in a single assay. U.S. 5:1996;514-543.
21. Haines J.L., Ter-Minassian M., Bazyk A., Gusella J.F., Kim D.J., Terwedow H., Pericak-Vance M.A., Rimmler J.B., Haynes C.S., Roses A.D., Lee A., Shaner B., Menold M., Seboun E., Fitoussi R.P., Gartioux C., Reyes C., Ribierre F., Gyapay G., Weissenbach J., Hauser S.L., Goodkin D.E., Lincoln R., Usuku K., Garcia-Merino A., Gatto N., Young S., Okensberg J.R. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
22. Hobart M.J., Fernie B.A., DiScipio R.G., Lachmann P.J. Structure and gross arrangement of the C6 and C7 genes. Mol. Immunol. 30:1993;16.
23. Jans H., Sorensen H. C3 polymorphism and circulating immune complexes in patients with multiple sclerosis. Acta Neurol. Scand. 62:1980;237-243.
24. Kalman B., Takacs K., Gyodi E., Kramer J., Fust G., Tauszik T. Sclerosis mulitplex in Gypsies. Acta. Neurol. Scand. 84:1991;181-185.
25. Kruglyak L. The use of a genetic map of biallelic markers in linkage studies. Nat. Genet. 17:1997;21-24.
26. Kruglyak L., Lander E.S. High-resolution genetic mapping of complex traits. Am. J. Hum. Genet. 56:1995;1212-1223.
27. Kuokkanen S., Sundvall M., Terwilliger J.D., Tienari P.J., Wikstrom J., Holmdahl R., Pettersson U., Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13:1996;477-480.
28. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikstrom J., Palo J., Stein L.D., Hudson T.J., Lander E.S., Peltonen L. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61:1997;1379-1387.
29. Landegren U., Kaiser R., Sanders J., Hood L. A ligase-mediated gene detection technique. Science. 241:1988;1077-1080.
30. Lumsden C.E. The immunogenesis of the multiple sclerosis plaque. Brain Res. 28:1971;365-390.
31. Mollnes T.E., Lea T., Harboe M., Tschopp J. Monoclonal antibodies recognising a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma. Scand. J. Immunol. 22:1985;183-195.
32. Nickerson D.A., Kaiser R., Lappin S., Stewart J., Hood L., Landegren U. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc. Natl. Acad. Sci. USA. 87:1990;8923-8927.
33. Risch N. Linkage strategies for genetically complex traits: I. Multilocus models. Am. J. Hum. Genet. 46:1990;222-228.
34. Risch N., Merikangas K. Genetic analysis of complex diseases. Science. 275:1997;1329-1330.
35. Sanders M.E., Koski C.L., Robbins D., Shin M.L., Frank M.M., Somer K.A. Activated terminal complement in CSF in Guillain-Barre syndrome and multiple sclerosis. J. Immunol. 136:1986;4456-4459.
36. Sawcer S.J., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P.N., Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosomes 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
37. Sawcer S.J., Goodfellow P.N., Compston D.A.S. The genetic analysis of multiple sclerosis. TIGs. 13:1997;234-239.
38. Schafer A.J., Hawkins J.R. DNA variation and the future of human genetics. Nat. Biotechnol. 16:1998;33-39.
39. Scolding N.J., Morgan B.P., Houston A., Campbell A.K., Linington C., Compston D.A.S. Normal rat cytotoxicity against syngeneic oligodendrocytes: complement activation and attack in the absence of anti-myelin antibodies. J. Neurol. Sci. 89:1989;289-300.
40. Scolding N.J., Morgan B.P., Houston W.A.J., Linington C., Campbell A.K., Compston D.A.S. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature. 339:1989;620-622.
41. Setien F., Alvarez V., Coto E., DiScipio R.G., Lopez-Larrea C. A physical map of the human complement component C6, C7 and C9 genes. Immunogenetics. 38:1993;341-344.
42. Sobel R.A., Chen M., Maeda A., Hinojoza J.R. Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 54:1995;202-213.
43. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59:1996;983-989.
44. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
45. Stewart G.J., Basten A., Kirk R.L. Strong linkage disequilibrium between HLA-Dw2 and BfS in multiple sclerosis and in the normal population. Tissue Antigens. 14:1979;86-97.
46. Storch M.K., Piddlesden S., Haltia M., Iivanainen M., Morgan P., Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43:1998;465-471.
47. Woyciechowska J.L., Brzosko W.J. Immunofluorescence study of brain plaques from two patients with multiple sclerosis. Neurology. 27:1977;620-622.